0: Huang Z#, Zhuang X#, Zhang S#, Huang Y, Yuan L, Lin A, Tang L, Xiong Z,Christopher O, Chen Y, Wu B, Ling Y, Li S, Jie Q, Xiong L, Qian X, Liao X*, LiuJ*. Alirocumab effect on preventing periprocedural ischaemic events in coronaryheart disease patients undergoing coronary stenting (APPEASE trial): studyprotocol of a multicentre, open-label, randomised controlled trial. BMJ Open.2023 Jul 11;13(7):e072541
1: Lin YF#, Li MH#, Huang RH#, Zhang SZ, Xu XF, Zhou HM, Liu MH, Liao XX, Liao LZ,Guo Y*, Zhuang XD*. GP73 enhances the ox-LDL-induced inflammatory response inTHP-1 derived macrophages via affecting NLRP3 inflammasome signaling. Int JCardiol. 2023 Sep 15;387:131109
2: Ke Z#, Huang R#, Xu X#, Liu W, Wang S, Zhang X, Guo Y, Zhuang X*, Zhen L*. Long-Term High Level of Insulin Resistance Is Associated With an Increased Prevalenceof Coronary Artery Calcification: The CARDIA Study. J Am Heart Assoc. 2023 Jun6;12(11):e028985
3: Liu M#, Xu X#, Chen X#, Guo Y, Zhang S, Lin Y, Zhou H, Li M, Xie P, Xia W, WangL, Zhuang X*, Liao X*. Body Weight Time in Target Range and CardiovascularOutcomes in Adults with Overweight/Obesity and Type 2 Diabetes. Eur J PrevCardiol. 2023 May 22:zwad165
4: Zhan R#, Zhang J#, Chen X#, Liu T, He Y, Zhang S, Liao X, Zhuang X, Tian T*, FengL*. Targeting the Efficacy of Intensive Blood Pressure Treatment in HypertensivePatientsã€€- An Exploratory Analysis of SPRINT. Circ J. 2023 Apr 26
5: Li M#, Lin Y#, Zhong X#, Huang R, Zhang S, Liu M, Liu S, Ye X, Xu X, Huang Y,Xiong Z, Guo Y, Liao X*, Zhuang X*. Predictive Performance of EstablishedCardiovascular Risk Scores in the Prediabetic Population: External Validationusing the UK Biobank Dataset. Eur J Prev Cardiol. 2023 Apr 10:zwad106
6: Xu C#, Guo Y#, Zhang S#, Lai Y, Huang M, Zhan R, Liu M, Xiong Z, Huang Y, HuangR, Liao X, Zhuang X*, Cai Z*. Visceral adiposity index and the risk of heartfailure, late-life cardiac structure and function in ARIC Study. Eur J PrevCardiol. 2023 Apr 10:zwad099
7: Li K#, Li B#, Zhang D#, Du T, Zhou H, Dai G, Yan Y, Gao N, Zhuang X, Liao X, LiuC, Dong Y, Chen D, Qu LH, Ou J, Yang JH*, Huang ZP*. The translational landscapeof human vascular smooth muscle cells identifies novel short open reading frame-encoded peptide regulators for phenotype alteration. Cardiovasc Res. 2023 Jul6;119(8):1763-1779
8: Ye X#, Xiong Z#, Li J#, Lin Y, Xie P, Zhong X, Huang R, Zhuang X*, Liao X*.Changes in Cardiovascular Health during Young Adulthood and SubclinicalAtherosclerosis in Middle Age: The CARDIA Study. Glob Heart. 2023 Mar17;18(1):14
9: Wang P#, Liu M#, Zhuang X#, Guo Y, Xiong Z, He L, Cai X, Chen Z, Peng L*, LiaoX*. Association of metabolically healthy obesity in young adulthood withmyocardial structure and function. Int J Obes (Lond). 2023 May;47(5):399-405
10: Christopher O#, Xiong Z#, Huang Y#, Zhuang X, Zhang S, Liu M, Guo Y*, Liao X*.Risk score for coronary heart disease (CHD-RISK) and hemodynamically significantaortic valve stenosis. Nutr Metab Cardiovasc Dis. 2023 May;33(5):1029-1036
11: Zhong X#, Xu X#, Liu M#, Wang P, He L, Christopher O, Zhang S, Lin Y, Huang Y,Xiong Z, Zhuang X*, Liao X*. Effect of intensive lifestyle intervention on theassociation between weight variability and major adverse cardiovascular eventsin overweight or obese adults with type 2 diabetes mellitus. J DiabetesInvestig. 2023 Mar;14(3):441-451
12: Xiong Z#, Li J#, Lin Y#, Ye X, Xie P, Zhang S, Liu M, Huang Y, Liao X*, ZhuangX*. Intensity of hypertensive exposure in young adulthood and subclinicalatherosclerosis in middle age: Evidence from the CARDIA study. Front CardiovascMed. 2022 Dec 7;9:959146
13: He J#, Zhang S#, Qiu Y#, Liu F, Liu Z, Tan J, Hu F, Wu X, Wang Y, Zhou L, Hu S,Chen M, Liao X, Zhuang X*, Mao R*. Ulcerative colitis increases risk ofhypertension in a UK biobank cohort study. United European Gastroenterol J. 2023Feb;11(1):19-30
14: Lin Y#, Kong J#, Tian T#, Zhong X, Zhang S, Zhou H, Xiong Z, Zhao J, Huang Y,Liu M, Dong Y, Zheng J, Diao X, Wu J, Qin H, Hu Y, Wang X, Zhuang X*, Liao X*.Identification of Novel Phenotypes Correlated with CKD: A Phenotype-WideAssociation Study. Int J Med Sci. 2022 Oct 31;19(13):1920-1928
15: Wang SS#, Zhang X#, Ke ZZ#, Wen XY, Li WD, Liu WB, Zhuang XD*, Liao LZ*.D-galactose-induced cardiac ageing: A review of model establishment andpotential interventions. J Cell Mol Med. 2022 Nov;26(21):5335-5359
16: Zhou HM#, Zhan RJ#, Chen X#, Lin YF, Zhang SZ, Zheng H, Wang X, Huang MT, XuCG, Liao XX, Tian T*, Zhuang XD*. Targeting efficacy of spironolactone in patientswith heart failure with preserved ejection fraction: the TOPCAT study. ESC HeartFail. 2023 Feb;10(1):322-333
17: Huang Z#, Zhong J#, Zhang S#, Xiong Z, Huang Y, Liu M, Lin Y, Zhong X, Ye X,Zhuang X*, Liao X*. Association between serum cystatin C and early impairment ofcardiac function and structure in type 2 diabetes patients with normal renalfunction. Clin Cardiol. 2022 Dec;45(12):1287-1296
18: Zhou Z#, Zhuang X#, Liu M#, Jian B, Fu G, Liao X, Wu Z*, Liang M*. Leftventricular volume change and long-term outcomes in ischaemic cardiomyopathywith or without surgical revascularisation: A post-hoc analysis of a randomisedcontrolled trial. EClinicalMedicine. 2022 Aug 27;53:101626
19: Huang R#, Wu R#, Lin Y#, Zhong X, Ye X, Zhuang X*, Liao X*. Time-averagedcumulative blood pressure and cardiovascular outcomes in heart failure withpreserved ejection fraction: analysis from the Treatment of Preserved CardiacFunction Heart Failure with an Aldosterone Antagonist trial. J Hypertens. 2022Oct 1;40(10):1918-1926
20: Ye J#, Zhuang X#, Li X#, Gong X, Sun Y, Wang W, Feng S, Wu T*, Zhong B*. Novelmetabolic classification for extrahepatic complication of metabolic associatedfatty liver disease: A data-driven cluster analysis with internationalvalidation. Metabolism. 2022 Nov;136:155294
21: Xu X#, Huang R#, Lin Y#, Guo Y, Xiong Z, Zhong X, Ye X, Li M, Zhuang X*, Liao X*.High triglyceride-glucose index in young adulthood is associated with incidentcardiovascular disease and mortality in later life: insight from the CARDIAstudy. Cardiovasc Diabetol. 2022 Aug 12;21(1):155
22: Huang Y#, Zhou H#, Zhang S#, Zhong X, Lin Y, Xiong Z, Liu M, Yimamu A,Christopher O, Zhou Z, Zhuang X*, Liao X*. Mid- to Late-Life Time-AveragedCumulative Blood Pressure and Late-Life Retinal Microvasculature: The ARICStudy. J Am Heart Assoc. 2022 Aug 2;11(15):e25226
23: Christopher O#, Huang Y#, Xiong Z#, Zhuang X*, Liao X*. Serum cystatin C,cystatin C level change and risk of atrial fibrillation. Eur J Intern Med. 2022Sep;103:126-127
24: Yan T#, Huang Y#, Wu JHY#, Zhuang XD*, Pan XF*. Editorial: Insulin Resistance,Metabolic Syndrome, and Cardiovascular Disease. Front Cardiovasc Med. 2022 Jun22;9:959680
25: Liu M#, Huang R#, Xu L#, Zhang S, Zhong X, Chen X, Lin Y, Xiong Z, Wang L, LiaoX*, Zhuang X*. Cardiovascular effects of intensive lifestyle intervention inadults with overweight/obesity and type 2 diabetes according to body weight timein range. EClinicalMedicine. 2022 May 27;49:101451
26: Li W#, Liu XD#, Liu YQ#, Zhuang XD, Wu ZK*, Yao FJ*. Diagnosis of left anteriordescending branch-right ventricular fistula with giant coronary artery aneurysmby contrast echocardiography: A case report. Echocardiography. 2022Jul;39(7):935-939
27: Huang R#, Lin Y#, Ye X#, Zhong X, Xie P, Li M, Zhuang X*, Liao X*. Triglyceride-glucose index in the development of heart failure and left ventriculardysfunction: analysis of the ARIC study. Eur J Prev Cardiol. 2022 Aug22;29(11):1531-1541
28: Liu M#, Chen X#, Zhang S#, Lin J, Wang L, Liao X*, Zhuang X*. Assessment ofVisit-to-Visit Blood Pressure Variability in Adults With Optimal Blood Pressure:A New Player in the Evaluation of Residual Cardiovascular Risk? J Am HeartAssoc. 2022 May 3;11(9):e022716. 
29: Fan Y#, Zhang G#, Zhang Z#, Zhang S, Liu M, Lin Y, Huang Y, Zhong X, Zhuang X*,Liao X*. Critical Appraisal of Guidelines for Antithrombotic Therapy in AtrialFibrillation Post-Percutaneous Coronary Intervention. Glob Heart. 2022 Feb23;17(1):14
30: Han Y#, Du T#, Guo S#, Wang L, Dai G, Long T, Xu T, Zhuang X, Liu C, Li S,Zhang D, Liao X, Dong Y, Lui KO, Tan X, Lin S, Chen Y*, Huang ZP*. Loss ofm<sup>6</sup>A Methyltransferase METTL5 Promotes Cardiac Hypertrophy ThroughEpitranscriptomic Control of SUZ12 Expression. Front Cardiovasc Med. 2022 Feb28;9:852775
31: Huang R#, Lin Y#, Liu M#, Xiong Z, Zhang S, Zhong X, Ye X, Huang Y, Zhuang X*,Liao X*. Time in Target Range for Systolic Blood Pressure and CardiovascularOutcomes in Patients With Heart Failure With Preserved Ejection Fraction. J AmHeart Assoc. 2022 Apr 5;11(7):e022765
32: Zhuang XD#, Tian T#, Liao LZ#, Dong YH, Zhou HJ, Zhang SZ, Chen WY, Du ZM, WangXQ*, Liao XX*. Deep Phenotyping and Prediction of Long-term CardiovascularDisease: Optimized by Machine Learning. Can J Cardiol. 2022 Jun;38(6):774-782
33: Christopher O#, Xu XF#, Lin YF#, Zhang SZ, Huang YQ, Zhong XB, Xiong ZY, ChenTSR, Xu CG, Zhuang XD*, Liao XX*. Association between serum cystatin C level andhemodynamically significant aortic stenosis: a prospective cohort study. JGeriatr Cardiol. 2021 Dec 28;18(12):986-995
34: Zhou Z#, Liang M#, Zhuang X#, Liu M, Fu G, Liu Q, Liao X*, Wu Z*. Long-termOutcomes After On-Pump vs Off-Pump Coronary Artery Bypass Grafting for IschemicCardiomyopathy. Ann Thorac Surg. 2023 Jun;115(6):1421-1428
35: Lai Y#, Zhuang X#*, Liao X#*. Letter by Lai et al Regarding Article,"Cardiovascular Risk Factor Trajectories Since Childhood and CognitivePerformance in Midlife: The Cardiovascular Risk in Young Finns Study".Circulation. 2021 Nov 16;144(20):e307
36: Li-Zhen L#, Chen ZC#, Wang SS#, Liu WB*, Zhuang XD*. Klotho deficiency causescardiac ageing by impairing autophagic and activating apoptotic activity. Eur JPharmacol. 2021 Nov 15;911:174559
37: Xiong Z#, Xie P#, Li J#, Chen ZC, Lin Y, Liu M, Zhang S, Zhong X, Zhou H,Zhuang X*, Liao X*. Visit-to-Visit Fasting Glucose Variability in Young Adulthoodand Cardiac Structure and Function at Midlife: The CARDIA Study. FrontCardiovasc Med. 2021 Sep 16;8:687054
38: Zhou Z#, Chen J#, Fu G#, Zhuang X, Hou J, Chen S, Huang S, Yue Y, Shang L, WangK, Lv L, Liang M*, Wu Z*. Association of Post-operative Systolic Blood PressureVariability With Mortality After Coronary Artery Bypass Grafting. FrontCardiovasc Med. 2021 Aug 12;8:717073
39: Liao LZ#, Chen ZC#, Wang SS#, Liu WB, Zhao CL*, Zhuang XD*. NLRP3 inflammasomeactivation contributes to the pathogenesis of cardiocytes aging. Aging (AlbanyNY). 2021 Aug 25;13(16):20534-20551
40: Li Y#, Jiang K#, Yang J#, Zheng Y, HÃ¼bner R, Ou Z, Dong X, He L, Wang H, Li J,Sun Y, Lu X, Zhuang X, Zheng Z*, Liu W*. Tungsten Oxide/Reduced Graphene OxideAerogel with Low-Content Platinum as High-Performance Electrocatalyst forHydrogen Evolution Reaction. Small. 2021 Sep;17(37):e2102159
41: Lin Y#, Zhong X#, Xiong Z#, Zhang S, Liu M, Fan Y, Huang Y, Sun X, Zhou H, XuX, Guo Y, Li Y, Yang D, Ye X, Zhuang X*, Liao X*. Intensity of Glycemic Exposurein Early Adulthood and Target Organ Damage in Middle Age: The CARDIA Study.Front Physiol. 2021 Jun 23;12:614532
42: Liu M#, Chen X#, Zhang S#, Lin Y, Xiong Z, Zhong X, Guo Y, Sun X, Zhou H, Xu X,Wang L, Liao X*, Zhuang X*. Long-Term Visit-to-Visit Mean Arterial PressureVariability and the Risk of Heart Failure and All-Cause Mortality. FrontCardiovasc Med. 2021 Jun 4;8:665117
43: Lin Y#, Zhang S#, Wang S#, Zhong X, Li Y, Xiong Z, Sun X, Huang Y, Fan Y, GuoY, Zhou H, Yang D, Liu M, Xu X, Zhuang X*, Liao X*. Behavioral Factors Mediatingthe Impact of Educational Attainment on Incident Heart Failureã€€- A MediationAnalysis. Circ J. 2021 Aug 25;85(9):1545-1552
44: Guo Y#, Zou J#, Xu X#, Zhou H, Sun X, Wu L, Zhang S, Zhong X, Xiong Z, Lin Y,Huang Y, Du Z, Liao X*, Zhuang X*. Short-chain fatty acids combined with intronicDNA methylation of HIF3A: Potential predictors for diabetic cardiomyopathy. ClinNutr. 2021 Jun;40(6):3708-3717
45: Zang J#, Shi J#, Liang J#, Zhang X, Wei W, Yao C, Zhuang X*, Wu G*. PulsePressure, Cognition, and White Matter Lesions: A Mediation Analysis. FrontCardiovasc Med. 2021 May 4;8:654522
46: Wang K#, Zhang Z#, Mo ZS#, Yang XH, Lin BL, Peng L, Xu Y, Lei CY, Zhuang XD, LuL, Yang RF, Chen T*, Gao ZL*. Gut microbiota as prognosis markers for patientswith HBV-related acute-on-chronic liver failure. Gut Microbes. 2021 Jan-Dec;13(1):1-15
47: Liu M#, Zhang S#, Chen X#, Guo Y, Zhong X, Xiong Z, Lin Y, Zhou H, Huang Y,Zhang Z, Wang L, Zhuang X*, Liao X*. Appraisal of Guidelines for the Management ofBlood Pressure in Patients with Diabetes Mellitus: The Consensuses,Controversies and Gaps. Diabetes Metab J. 2021 Sep;45(5):753-764
48: Liao LZ#, Wen XY#, Zhang SZ#, Li WD*, Zhuang XD*. Hypertension and AtrialFibrillation: A Study on Epidemiology and Mendelian Randomization Causality.Front Cardiovasc Med. 2021 Mar 23;8:644405
49: Lin Y#, Zhong X#, Liu M#, Zhang S, Xiong Z, Huang Y, Fan Y, Xu X, Guo Y, Li Y,Sun X, Zhou H, Yang D, Ye X, Liao X*, Zhuang X*. Risk Stratification and Efficacyof Spironolactone in Patients with Heart Failure with Preserved EjectionFraction: Secondary Analysis of the TOPCAT Randomized Clinical Trial. CardiovascDrugs Ther. 2022 Apr;36(2):323-331
50: Chen Z#, Liu M#, Zhang S#, Xiong Z, Zhong X, Yang D, Kong J, He X, Zhu Y, Hu X*,Zhuang X*. Urban index and lifestyle risk factors for cardiovascular diseases inChina: A cross-sectional study. Sci Prog. 2021 Jan-Mar;104(1):368504211003762
51: Liao LZ#, Chen ZC#, Li WD#, Zhuang XD*, Liao XX*. Causal effect of education ontype 2 diabetes: A network Mendelian randomization study. World J Diabetes. 2021Mar 15;12(3):261-277
52: Liu M#, Zhang S#, Chen X#, Zhong X, Xiong Z, Yang D, Lin Y, Huang Y, Li Y, WangL, Zhuang X*, Liao X*. Association of Mid- to Late-Life Blood Pressure PatternsWith Risk of Subsequent Coronary Heart Disease and Death. Front Cardiovasc Med.2021 Feb 15;8:632514
53: Zang J#, Liang J#, Zhuang X#, Zhang S, Liao X*, Wu G*. Intensive blood pressuretreatment in coronary artery disease: implications from the Systolic BloodPressure Intervention Trial (SPRINT). J Hum Hypertens. 2022 Jan;36(1):86-94
54: Zhuang X#, Sun X#, Zhou H#, Zhang S, Zhong X, Xu X, Guo Y, Xiong Z, Liu M, LinY, Zhang M*, Liao X*. Klotho attenuated Doxorubicin-induced cardiomyopathy byalleviating Dynamin-related protein 1 - mediated mitochondrial dysfunction. MechAgeing Dev. 2021 Apr;195:111442
55: Xie P#, Zhuang X#, Liu M#, Zhang S, Liu J, Liu D*, Liao X*. An appraisal ofclinical practice guidelines for the appropriate use of echocardiography foradult infective endocarditis-the timing and mode of assessment (TTE or TEE). BMCInfect Dis. 2021 Jan 21;21(1):92
56: Zhang S#, Zhuang X#, Lv Q#, Du Z, Zhou H, Zhong X, Sun X, Xiong Z, Hu X, YangD, Zhang M*, Liao X*. Six-Year Change in QT Interval Duration and Risk of IncidentHeart Failureã€€- A Secondary Analysis of the Atherosclerosis Risk in CommunitiesStudy. Circ J. 2021 Apr 23;85(5):640-646
57: Zhuang XD#, Zhang SZ#, Liao LZ#, Lin X, Zhou HM, Zhong XB, Sun XT, Du ZM, ZhangMF*, Liao XX*. Serum Albumin and Incident Heart Failure: Insights FromEpidemiological and Mendelian Randomization Studies. Circ Genom Precis Med. 2020Dec;13(6):e002989
58: Liao LZ#, Zhuang XD#, Zhang SZ#, Liao XX*, Li WD*. Education and heart failure:New insights from the atherosclerosis risk in communities study and mendelianrandomization study. Int J Cardiol. 2021 Feb 1;324:115-121
59: Sun XT#, Zeng C#, Zhang SZ#, Zhou HM, Zhong XB, Xiong ZY, Yang DY, Guo Y,Zhuang XD*, Liao XX*. Long-term tracking of fasting blood glucose variability andperipheral artery disease in people without diabetes. BMJ Open Diabetes ResCare. 2020 Sep;8(1):e000896
60: Zhang ZZ#, Zhang SZ#, Zhou HM#, Fan YQ, Liu MH, Zhong XB, Yang DY, Guo Y,Zhuang XD*, Liao XX*. A systematic review of guidelines for dual antiplatelettherapy in coronary artery bypass graft. Eur J Clin Invest. 2021Jan;51(1):e13405
61: Chen T#, Liu L#, Zhang L#, Lu T, Matos RL, Jiang C, Lin Y, Yuan T, Ma Z, He H,Zhuang X*, Li Q*. Optimization of the supercritical fluidized bed process forsirolimus coating and drug release. Int J Pharm. 2020 Nov 15;589:119809
62: Huang Y#, Zhang S#, Liu M#, Zhong X, Lin Y, Xiong Z, Fan Y, Zhou H, Sun X, GuoY, Xu X, Li Y, Yang D, Zhuang X*, Liao X*. Impact of RAAS Blockers on Contrast-Induced Nephropathy in Patients With Renal Insufficiency: A Meta-Analysis. JCardiovasc Pharmacol. 2020 Dec;76(6):692-697
63: Liu M#, Zhuang X#, Chen X#, Zhang S, Yang D, Zhong X, Xiong Z, Lin Y, Zhou H,Fan Y, Xie P, Huang Y, Wang L*, Liao X*. Antiplatelet strategy in primary andsecondary prevention of cardiovascular disease in patients with typeÂ 2 diabetesmellitus: A perspective from the guideline appraisal. J Diabetes Investig. 2021Jan;12(1):99-108
64: Hu X#, Zhuang XD#, Mei WY#, Liu G, Du ZM, Liao XX*, Li Y*. Exploring the causalpathway from body mass index to coronary heart disease: a network Mendelianrandomization study. Ther Adv Chronic Dis. 2020 May 27;11:2040622320909040
65: Liang J#, Zhang H#, Sun X#, Liao L, Li X, Hu X, Du J, Zhuang X*, Liao X*.Association between calf girth and peripheral artery disease in theAtherosclerosis Risk in Communities Study. J Cardiol. 2020 Sep;76(3):273-279
66: Liao LZ#, Li WD#, Liu Y#, Li JP, Zhuang XD*, Liao XX*. Causal assessment of sleepon coronary heart disease. Sleep Med. 2020 Mar;67:232-236
67: Liao LZ#, Zhang SZ#, Li WD#, Liu Y, Li JP, Zhuang XD*, Liao XX*. Serum albuminand atrial fibrillation: insights from epidemiological and mendelianrandomization studies. Eur J Epidemiol. 2020 Feb;35(2):113-122
68: Zhang L#, Sun X#, Liao L#, Zhang S, Zhou H, Zhong X, Zhuang X*, Liao X*.Effectiveness of blood pressure-lowering treatment by the levels of baselineFramingham risk score: A post hoc analysis of the Systolic Blood PressureIntervention Trial (SPRINT). J Clin Hypertens (Greenwich). 2019Dec;21(12):1813-1820
69: Liu C#, Cao Y#, He X#, Zhang C, Liu J, Zhang L, Wu D, Zhuang X, Xue R, Huang H,Jiang J, Dong B, Sun Y, Dong Y*, Zhao J*. Association of Cyr61-cysteine-richprotein 61 and short-term mortality in patients with acute heart failure andcoronary heart disease. Biomark Med. 2019 Dec;13(18):1589-1597
70: Liao LZ#, Li WD#, Liu Y#, Li JP, Zhuang XD*, Liao XX*. Exploring the causalpathway from omega-6 levels to coronary heart disease: A network Mendelianrandomization study. Nutr Metab Cardiovasc Dis. 2020 Feb 10;30(2):233-240
71: Zhang S#, Zhou H#, Zhuang X#, Yang D, Sun X, Zhong X, Lin X, Hu X, Huang Y,Liao X*, Du Z*. Critical appraisal of guidelines for coronary artery disease ondual antiplatelet therapy: More consensus than controversies. Clin Cardiol. 2019Dec;42(12):1170-1180
72: Zhou H#, Zhang S#, Sun X#, Yang D, Zhuang X, Guo Y, Hu X, Du Z, Zhang M*, LiaoX*. Lipid management for coronary heart disease patients: an appraisal of updatedinternational guidelines applying Appraisal of Guidelines for Research andEvaluation II-clinical practice guideline appraisal for lipid management incoronary heart disease. J Thorac Dis. 2019 Aug;11(8):3534-3546
73: Xiong Z#, Li J#, Zhong X#, Zhang S, Sun X, Zhou H, Chen Y, Zhuang X*, Liao X*.Visit-to-Visit Fasting Glucose Variability in Young Adulthood and HippocampalIntegrity and Volume at Midlife. Diabetes Care. 2019 Dec;42(12):2334-2337
74: Zhang S#, Zhuang X#*, Liao X#*. Letter by Zhang et al Regarding Article, "TwentyYear Trends and Sex Differences in Young Adults Hospitalized With AcuteMyocardial Infarction: The ARIC Community Surveillance Study". Circulation. 2019Aug 20;140(8):e329-e330
75: Yang DY#, Nie ZQ#, Liao LZ#, Zhang SZ, Zhou HM, Sun XT, Zhong XB, Du ZM, ZhuangXD*, Liao XX*. Phenomapping of subgroups in hypertensive patients usingunsupervised data-driven cluster analysis: An exploratory study of the SPRINTtrial. Eur J Prev Cardiol. 2019 Nov;26(16):1693-1706
76: Zhang S#, Zhuang X#, Lin X#, Zhong X, Zhou H, Sun X, Xiong Z, Huang Y, Fan Y,Guo Y, Du Z*, Liao X*. Low-Carbohydrate Diets and Risk of Incident AtrialFibrillation: AÂ Prospective Cohort Study. J Am Heart Assoc. 2019 May7;8(9):e011955
77: Yang DY#, He X#, Liang HW#, Zhang SZ, Zhong XB, Luo CF, Du ZM, He JG, ZhuangXD*, Liao XX*. Comparative outcomes of heart failure among existent classes ofanti-diabetic agents: a network meta-analysis of 171,253 participants from 91randomized controlled trials. Cardiovasc Diabetol. 2019 Apr 8;18(1):47
78: He Y#, Zhu Z#, Chen Y#, Chen F, Wang Y, Ouyang C, Yang H, Huang M, Zhuang X,Mao R, Ben-Horin S, Wu X, Ouyang Q, Qian J, Lu N, Hu P*, Chen M*. Development andValidation of a Novel Diagnostic Nomogram to Differentiate Between IntestinalTuberculosis and Crohn's Disease: A 6-year Prospective Multicenter Study. Am JGastroenterol. 2019 Mar;114(3):490-499
79: Sun X#, Zhuang X#, Huo M#, Feng P, Zhang S, Zhong X, Zhou H, Guo Y, Hu X, Du Z,Zhang M*, Liao X*. Serum magnesium and the prevalence of peripheral arterydisease: The Atherosclerosis Risk in Communities (ARIC) study. Atherosclerosis.2019 Mar;282:196-201
80: Sun X#, Guo Y#, Nie Z#, Cheng J, Zhou H, Zhong X, Zhang S, Du Z, Zhuang X*, LiaoX*. Influence of baseline systolic blood pressure on the relationship betweenintensive blood pressure control and cardiovascular outcomes in the SystolicBlood Pressure Intervention Trial (SPRINT). Clin Res Cardiol. 2019Mar;108(3):273-281
81: Zhang J#, Xiao Y#, Yang D#, Zhuang X, Wang L, Gao X*, Huang Z*. Correction to:Development of a new risk nomogram of perioperative major adverse cardiac eventsfor Chinese patients undergoing colorectal carcinoma surgery. Int J ColorectalDis. 2018 Aug;33(8):1147
82: Zhuang X#, Guo Y#, Ni A#, Yang D, Liao L, Zhang S, Zhou H, Sun X, Wang L, WangX*, Liao X*. Toward a panoramic perspective of the association betweenenvironmental factors and cardiovascular disease: An environment-wideassociation study from National Health and Nutrition Examination Survey1999-2014. Environ Int. 2018 Sep;118:146-153
83: Zhuang XD#, He X#, Yang DY#, Guo Y, He JG, Xiao HP*, Liao XX*. Comparativecardiovascular outcomes in the era of novel anti-diabetic agents: acomprehensive network meta-analysis of 166,371 participants from 170 randomizedcontrolled trials. Cardiovasc Diabetol. 2018 Jun 5;17(1):79
84: Zhang L#, Zhuang X#*, Liao X#*. A proposed Oxford classification-basedclinicopathological nomogram for predicting short-term renal outcomes in IgAnephropathy after acute kidney injury. Eur J Intern Med. 2018 Jun;52:60-66
85: Liao L#, Zhuang X#, Li W#, Su Q, Zhao J*, Liu Y*. Polysaccharide from Fuziprotects against Oxâ€‘LDLâ€‘induced calcification of human vascular smooth musclecells by increasing autophagic activity. Mol Med Rep. 2018 Apr;17(4):5109-5115
86: Zhuang X#, Ni A#, Liao L#, Guo Y, Dai W, Jiang Y, Zhou H, Hu X, Du Z, Wang X*,Liao X*. Environment-wide association study to identify novel factors associatedwith peripheral arterial disease: Evidence from the National Health andNutrition Examination Survey (1999-2004). Atherosclerosis. 2018 Feb;269:172-177
87: Long M#, Huang Z#, Zhuang X#, Huang Z, Guo Y, Liao X*, Luo C*. Association ofInflammation and Endothelial Dysfunction with Coronary Microvascular Resistancein Patients with Cardiac Syndrome X. Arq Bras Cardiol. 2017 Nov;109(5):397-403
88: Guo Y#, Zhuang X#, Huang Z#, Zou J, Yang D, Hu X, Du Z, Wang L*, Liao X*. Klothoprotects the heart from hyperglycemia-induced injury by inactivating ROS and NF-ÎºB-mediated inflammation both in vitro and in vivo. Biochim Biophys Acta MolBasis Dis. 2018 Jan;1864(1):238-251
89: Guo Y#, Zhuang XD#, Xian WB#, Wu LL, Huang ZN, Hu X, Zhang XS, Chen L*, Liao XX*.Serum Klotho, vitamin D, and homocysteine in combination predict the outcomes ofChinese patients with multiple system atrophy. CNS Neurosci Ther. 2017Aug;23(8):657-666
90: Zhang J#, Xiao Y#, Yang D#, Zhuang X, Wang L, Gao X*, Huang Z*. Development of anew risk nomogram of perioperative major adverse cardiac events for Chinesepatients undergoing colorectal carcinoma surgery. Int J Colorectal Dis. 2017Aug;32(8):1157-1164
91: Lu Y#, Hu XM#, Huang XL#, Zhuang XD, Guo P, Feng LF, Hu W, Chen L, Zou H*, HaoYT*. The relationship between job satisfaction, work stress, work-familyconflict, and turnover intention among physicians in Guangdong, China: a cross-sectional study. BMJ Open. 2017 May 12;7(5):e014894
92: Hu X#, Zhuang XD#, Li Y#, Li FF, Guo Y, Du ZM*, Liao XX*. A Nomogram to PredictContrast Induced Nephropathy in Patients Undergoing Percutaneous CoronaryIntervention. Int Heart J. 2017 Apr 6;58(2):191-196
93: Huang Z#, Zhuang X#, Xie C#, Hu X, Dong X, Guo Y, Li S*, Liao X*. ExogenousHydrogen Sulfide Attenuates High Glucose-Induced Cardiotoxicity by InhibitingNLRP3 Inflammasome Activation by Suppressing TLR4/NF-ÎºB Pathway in H9c2 Cells.Cell Physiol Biochem. 2016;40(6):1578-1590
94: Huang Z#, Dong X#, Zhuang X#, Hu X, Wang L*, Liao X*. Exogenous hydrogen sulfideprotects against high glucoseâ€‘induced inflammation and cytotoxicity in H9c2cardiac cells. Mol Med Rep. 2016 Nov;14(5):4911-4917
95: Lu Y#, Hu XM#, Huang XL#, Zhuang XD, Guo P, Feng LF, Hu W, Chen L*, Hao YT*. Jobsatisfaction and associated factors among healthcare staff: a cross-sectionalstudy in Guangdong Province, China. BMJ Open. 2016 Jul 19;6(7):e011388
96: Zhuang X#, Peng Y#, Bardeesi AS#, Bardisi ES, Liao X*, Luo C*. Vesselheterogeneity of TIMI frame count and its relation to P-wave dispersion inpatients with coronary slow flow. J Thorac Dis. 2016 Mar;8(3):476-81
97: Zhuang XD#, Liao LZ#, Dong XB#, Hu X, Guo Y, Du ZM, Liao XX*, Wang LC*. Design,synthesis, and antihypertensive activity of curcumin-inspired compounds via ACEinhibition and vasodilation, along with a bioavailability study for possiblebenefit in cardiovascular diseases. Drug Des Devel Ther. 2016 Jan 5;10:129-39
98: Zhang H#, Zhuang XD#, Meng FH#, Chen L, Dong XB, Liu GH, Li JH, Dong Q, Xu JD*,Yang CT*. Calcitriol prevents peripheral RSC96 Schwann neural cells from highglucose & methylglyoxal-induced injury through restoration of CBS/H2Sexpression. Neurochem Int. 2016 Jan;92:49-57
99: He WM#, Luo YT#, Shui X#, Liao XX, Liu JL*, Zhuang XD*. Critical appraisal ofinternational guidelines on chronic heart failure: Can China AGREE? Int JCardiol. 2016 Jan 15;203:111-4. 
100: Luo D#, Zhuang X#, Luo C#, Long M, Deng C, Liao X*, Wang L*. Continuousangiotensin-(1-7) infusion improves myocardial calcium transient and calciumtransient alternans in ischemia-induced cardiac dysfunction rats. BiochemBiophys Res Commun. 2015 Nov 27;467(4):645-50
101: Chen J#, Zhuang X#, Long M#, Su C*, Wang L*. Efficacy and Safety of Edoxaban inNonvalvular Atrial Fibrillation: A Meta-analysis of Randomized ControlledTrials. J Stroke Cerebrovasc Dis. 2015 Dec;24(12):2710-9
102: Zhuang XD#, Liao LZ#, Guo Y#, Li Y, Liao XX, Hu X*, Du ZM*. Rationale and designof RETAIN study: Rosuvastatin Effect on Telomere-telomerase system in Acutecoronary syndrome patients undergoing percutaneous coronary Intervention. Int JCardiol. 2015 Apr 1;184:388-390
103: Zhou Y#, Guo Y#, Zhuang X#*, Du Z*. Docosahexanoic acid modifies low-densitylipoprotein receptor abundance in HepG2 cells via suppression of the LXRÎ±-Idolpathway. Mol Med Rep. 2015 Mar;11(3):2329-33
104: Chen J#, Zhuang X#, Liao L#, Liao X*, Wang L*. Efficacy of isolated leftventricular and biventricular pacing is differentially associated with baselineQRS duration in chronic heart failure: a meta-analysis of randomized controlledtrials. Heart Fail Rev. 2015 Jan;20(1):81-8
105: Zhuang XD#, Long M#, Li CL#, Hu CH, Du ZM*, Liao XX*. Efficacy and safety oflow-dose clopidogrel after 12-month dual antiplatelet therapy for patientshaving drug-eluting stent implantation. J Thorac Dis. 2014 May;6(5):459-65
106: Zhuang XD#, Hu X#, Long M#, Dong XB, Liu DH*, Liao XX*. Exogenous hydrogensulfide alleviates high glucose-induced cardiotoxicity via inhibition of leptinsignaling in H9c2 cells. Mol Cell Biochem. 2014 Jun;391(1-2):147-55
107: Zhuang XD#, Long M#, Li F#, Hu X, Liao XX*, Du ZM*. PDE5 inhibitor sildenafil inthe treatment of heart failure: a meta-analysis of randomized controlled trials.Int J Cardiol. 2014 Apr 1;172(3):581-7
108: Chen YL#, Zhuang XD#, Xu ZW#, Lu LH, Guo HL, Wu WK*, Liao XX*. HigenamineCombined with [6]-Gingerol Suppresses Doxorubicin-Triggered Oxidative Stress andApoptosis in Cardiomyocytes via Upregulation of PI3K/Akt Pathway. Evid BasedComplement Alternat Med. 2013;2013:970490
109: Peng L#, Zhuang X#, Liao L#, He X, Li J, Chen X, Lu G, Ma H*, Gao X*. Changes incell autophagy and apoptosis during age-related left ventricular remodeling inmice and their potential mechanisms. Biochem Biophys Res Commun. 2013 Jan11;430(2):822-6
0: Huang Z#, Zhuang X#, Zhang S#, Huang Y, Yuan L, Lin A, Tang L, Xiong Z, Christopher O, Chen Y, Wu B, Ling Y, Li S, Jie Q, Xiong L, Qian X, Liao X*, Liu J*. Alirocumab effect on preventing periprocedural ischaemic events in coronary heart disease patients undergoing coronary stenting (APPEASE trial): study protocol of a multicentre, open-label, randomised controlled trial. BMJ Open. 2023 Jul 11;13(7):e072541
1: Lin YF#, Li MH#, Huang RH#, Zhang SZ, Xu XF, Zhou HM, Liu MH, Liao XX, Liao LZ, Guo Y*, Zhuang XD*. GP73 enhances the ox-LDL-induced inflammatory response in THP-1 derived macrophages via affecting NLRP3 inflammasome signaling. Int J Cardiol. 2023 Sep 15;387:131109
2: Ke Z#, Huang R#, Xu X#, Liu W, Wang S, Zhang X, Guo Y, Zhuang X*, Zhen L*. Long- Term High Level of Insulin Resistance Is Associated With an Increased Prevalence of Coronary Artery Calcification: The CARDIA Study. J Am Heart Assoc. 2023 Jun 6;12(11):e028985
3: Liu M#, Xu X#, Chen X#, Guo Y, Zhang S, Lin Y, Zhou H, Li M, Xie P, Xia W, Wang L, Zhuang X*, Liao X*. Body Weight Time in Target Range and Cardiovascular Outcomes in Adults with Overweight/Obesity and Type 2 Diabetes. Eur J Prev Cardiol. 2023 May 22:zwad165
4: Zhan R#, Zhang J#, Chen X#, Liu T, He Y, Zhang S, Liao X, Zhuang X, Tian T*, Feng L*. Targeting the Efficacy of Intensive Blood Pressure Treatment in Hypertensive Patientsã€€- An Exploratory Analysis of SPRINT. Circ J. 2023 Apr 26
5: Li M#, Lin Y#, Zhong X#, Huang R, Zhang S, Liu M, Liu S, Ye X, Xu X, Huang Y, Xiong Z, Guo Y, Liao X*, Zhuang X*. Predictive Performance of Established Cardiovascular Risk Scores in the Prediabetic Population: External Validation using the UK Biobank Dataset. Eur J Prev Cardiol. 2023 Apr 10:zwad106
6: Xu C#, Guo Y#, Zhang S#, Lai Y, Huang M, Zhan R, Liu M, Xiong Z, Huang Y, Huang R, Liao X, Zhuang X*, Cai Z*. Visceral adiposity index and the risk of heart failure, late-life cardiac structure and function in ARIC Study. Eur J Prev Cardiol. 2023 Apr 10:zwad099
7: Li K#, Li B#, Zhang D#, Du T, Zhou H, Dai G, Yan Y, Gao N, Zhuang X, Liao X, Liu C, Dong Y, Chen D, Qu LH, Ou J, Yang JH*, Huang ZP*. The translational landscape of human vascular smooth muscle cells identifies novel short open reading frame- encoded peptide regulators for phenotype alteration. Cardiovasc Res. 2023 Jul 6;119(8):1763-1779
8: Ye X#, Xiong Z#, Li J#, Lin Y, Xie P, Zhong X, Huang R, Zhuang X*, Liao X*. Changes in Cardiovascular Health during Young Adulthood and Subclinical Atherosclerosis in Middle Age: The CARDIA Study. Glob Heart. 2023 Mar 17;18(1):14
9: Wang P#, Liu M#, Zhuang X#, Guo Y, Xiong Z, He L, Cai X, Chen Z, Peng L*, Liao X*. Association of metabolically healthy obesity in young adulthood with myocardial structure and function. Int J Obes (Lond). 2023 May;47(5):399-405
10: Christopher O#, Xiong Z#, Huang Y#, Zhuang X, Zhang S, Liu M, Guo Y*, Liao X*. Risk score for coronary heart disease (CHD-RISK) and hemodynamically significant aortic valve stenosis. Nutr Metab Cardiovasc Dis. 2023 May;33(5):1029-1036
11: Zhong X#, Xu X#, Liu M#, Wang P, He L, Christopher O, Zhang S, Lin Y, Huang Y, Xiong Z, Zhuang X*, Liao X*. Effect of intensive lifestyle intervention on the association between weight variability and major adverse cardiovascular events in overweight or obese adults with type 2 diabetes mellitus. J Diabetes Investig. 2023 Mar;14(3):441-451
12: Xiong Z#, Li J#, Lin Y#, Ye X, Xie P, Zhang S, Liu M, Huang Y, Liao X*, Zhuang X*. Intensity of hypertensive exposure in young adulthood and subclinical atherosclerosis in middle age: Evidence from the CARDIA study. Front Cardiovasc Med. 2022 Dec 7;9:959146
13: He J#, Zhang S#, Qiu Y#, Liu F, Liu Z, Tan J, Hu F, Wu X, Wang Y, Zhou L, Hu S, Chen M, Liao X, Zhuang X*, Mao R*. Ulcerative colitis increases risk of hypertension in a UK biobank cohort study. United European Gastroenterol J. 2023 Feb;11(1):19-30
14: Lin Y#, Kong J#, Tian T#, Zhong X, Zhang S, Zhou H, Xiong Z, Zhao J, Huang Y, Liu M, Dong Y, Zheng J, Diao X, Wu J, Qin H, Hu Y, Wang X, Zhuang X*, Liao X*. Identification of Novel Phenotypes Correlated with CKD: A Phenotype-Wide Association Study. Int J Med Sci. 2022 Oct 31;19(13):1920-1928
15: Wang SS#, Zhang X#, Ke ZZ#, Wen XY, Li WD, Liu WB, Zhuang XD*, Liao LZ*. D-galactose-induced cardiac ageing: A review of model establishment and potential interventions. J Cell Mol Med. 2022 Nov;26(21):5335-5359
16: Zhou HM#, Zhan RJ#, Chen X#, Lin YF, Zhang SZ, Zheng H, Wang X, Huang MT, Xu CG, Liao XX, Tian T*, Zhuang XD*. Targeting efficacy of spironolactone in patients with heart failure with preserved ejection fraction: the TOPCAT study. ESC Heart Fail. 2023 Feb;10(1):322-333
17: Huang Z#, Zhong J#, Zhang S#, Xiong Z, Huang Y, Liu M, Lin Y, Zhong X, Ye X, Zhuang X*, Liao X*. Association between serum cystatin C and early impairment of cardiac function and structure in type 2 diabetes patients with normal renal function. Clin Cardiol. 2022 Dec;45(12):1287-1296
18: Zhou Z#, Zhuang X#, Liu M#, Jian B, Fu G, Liao X, Wu Z*, Liang M*. Left ventricular volume change and long-term outcomes in ischaemic cardiomyopathy with or without surgical revascularisation: A post-hoc analysis of a randomised controlled trial. EClinicalMedicine. 2022 Aug 27;53:101626
19: Huang R#, Wu R#, Lin Y#, Zhong X, Ye X, Zhuang X*, Liao X*. Time-averaged cumulative blood pressure and cardiovascular outcomes in heart failure with preserved ejection fraction: analysis from the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist trial. J Hypertens. 2022 Oct 1;40(10):1918-1926
20: Ye J#, Zhuang X#, Li X#, Gong X, Sun Y, Wang W, Feng S, Wu T*, Zhong B*. Novel metabolic classification for extrahepatic complication of metabolic associated fatty liver disease: A data-driven cluster analysis with international validation. Metabolism. 2022 Nov;136:155294
21: Xu X#, Huang R#, Lin Y#, Guo Y, Xiong Z, Zhong X, Ye X, Li M, Zhuang X*, Liao X*. High triglyceride-glucose index in young adulthood is associated with incident cardiovascular disease and mortality in later life: insight from the CARDIA study. Cardiovasc Diabetol. 2022 Aug 12;21(1):155
22: Huang Y#, Zhou H#, Zhang S#, Zhong X, Lin Y, Xiong Z, Liu M, Yimamu A, Christopher O, Zhou Z, Zhuang X*, Liao X*. Mid- to Late-Life Time-Averaged Cumulative Blood Pressure and Late-Life Retinal Microvasculature: The ARIC Study. J Am Heart Assoc. 2022 Aug 2;11(15):e25226
23: Christopher O#, Huang Y#, Xiong Z#, Zhuang X*, Liao X*. Serum cystatin C, cystatin C level change and risk of atrial fibrillation. Eur J Intern Med. 2022 Sep;103:126-127
24: Yan T#, Huang Y#, Wu JHY#, Zhuang XD*, Pan XF*. Editorial: Insulin Resistance, Metabolic Syndrome, and Cardiovascular Disease. Front Cardiovasc Med. 2022 Jun 22;9:959680
25: Liu M#, Huang R#, Xu L#, Zhang S, Zhong X, Chen X, Lin Y, Xiong Z, Wang L, Liao X*, Zhuang X*. Cardiovascular effects of intensive lifestyle intervention in adults with overweight/obesity and type 2 diabetes according to body weight time in range. EClinicalMedicine. 2022 May 27;49:101451
26: Li W#, Liu XD#, Liu YQ#, Zhuang XD, Wu ZK*, Yao FJ*. Diagnosis of left anterior descending branch-right ventricular fistula with giant coronary artery aneurysm by contrast echocardiography: A case report. Echocardiography. 2022 Jul;39(7):935-939
27: Huang R#, Lin Y#, Ye X#, Zhong X, Xie P, Li M, Zhuang X*, Liao X*. Triglyceride- glucose index in the development of heart failure and left ventricular dysfunction: analysis of the ARIC study. Eur J Prev Cardiol. 2022 Aug 22;29(11):1531-1541
28: Liu M#, Chen X#, Zhang S#, Lin J, Wang L, Liao X*, Zhuang X*. Assessment of Visit-to-Visit Blood Pressure Variability in Adults With Optimal Blood Pressure: A New Player in the Evaluation of Residual Cardiovascular Risk? J Am Heart Assoc. 2022 May 3;11(9):e022716. 
29: Fan Y#, Zhang G#, Zhang Z#, Zhang S, Liu M, Lin Y, Huang Y, Zhong X, Zhuang X*, Liao X*. Critical Appraisal of Guidelines for Antithrombotic Therapy in Atrial Fibrillation Post-Percutaneous Coronary Intervention. Glob Heart. 2022 Feb 23;17(1):14
30: Han Y#, Du T#, Guo S#, Wang L, Dai G, Long T, Xu T, Zhuang X, Liu C, Li S, Zhang D, Liao X, Dong Y, Lui KO, Tan X, Lin S, Chen Y*, Huang ZP*. Loss of m<sup>6</sup>A Methyltransferase METTL5 Promotes Cardiac Hypertrophy Through Epitranscriptomic Control of SUZ12 Expression. Front Cardiovasc Med. 2022 Feb 28;9:852775
31: Huang R#, Lin Y#, Liu M#, Xiong Z, Zhang S, Zhong X, Ye X, Huang Y, Zhuang X*, Liao X*. Time in Target Range for Systolic Blood Pressure and Cardiovascular Outcomes in Patients With Heart Failure With Preserved Ejection Fraction. J Am Heart Assoc. 2022 Apr 5;11(7):e022765
32: Zhuang XD#, Tian T#, Liao LZ#, Dong YH, Zhou HJ, Zhang SZ, Chen WY, Du ZM, Wang XQ*, Liao XX*. Deep Phenotyping and Prediction of Long-term Cardiovascular Disease: Optimized by Machine Learning. Can J Cardiol. 2022 Jun;38(6):774-782
33: Christopher O#, Xu XF#, Lin YF#, Zhang SZ, Huang YQ, Zhong XB, Xiong ZY, Chen TSR, Xu CG, Zhuang XD*, Liao XX*. Association between serum cystatin C level and hemodynamically significant aortic stenosis: a prospective cohort study. J Geriatr Cardiol. 2021 Dec 28;18(12):986-995
34: Zhou Z#, Liang M#, Zhuang X#, Liu M, Fu G, Liu Q, Liao X*, Wu Z*. Long-term Outcomes After On-Pump vs Off-Pump Coronary Artery Bypass Grafting for Ischemic Cardiomyopathy. Ann Thorac Surg. 2023 Jun;115(6):1421-1428
35: Lai Y#, Zhuang X#*, Liao X#*. Letter by Lai et al Regarding Article, "Cardiovascular Risk Factor Trajectories Since Childhood and Cognitive Performance in Midlife: The Cardiovascular Risk in Young Finns Study". Circulation. 2021 Nov 16;144(20):e307
36: Li-Zhen L#, Chen ZC#, Wang SS#, Liu WB*, Zhuang XD*. Klotho deficiency causes cardiac ageing by impairing autophagic and activating apoptotic activity. Eur J Pharmacol. 2021 Nov 15;911:174559
37: Xiong Z#, Xie P#, Li J#, Chen ZC, Lin Y, Liu M, Zhang S, Zhong X, Zhou H, Zhuang X*, Liao X*. Visit-to-Visit Fasting Glucose Variability in Young Adulthood and Cardiac Structure and Function at Midlife: The CARDIA Study. Front Cardiovasc Med. 2021 Sep 16;8:687054
38: Zhou Z#, Chen J#, Fu G#, Zhuang X, Hou J, Chen S, Huang S, Yue Y, Shang L, Wang K, Lv L, Liang M*, Wu Z*. Association of Post-operative Systolic Blood Pressure Variability With Mortality After Coronary Artery Bypass Grafting. Front Cardiovasc Med. 2021 Aug 12;8:717073
39: Liao LZ#, Chen ZC#, Wang SS#, Liu WB, Zhao CL*, Zhuang XD*. NLRP3 inflammasome activation contributes to the pathogenesis of cardiocytes aging. Aging (Albany NY). 2021 Aug 25;13(16):20534-20551
40: Li Y#, Jiang K#, Yang J#, Zheng Y, HÃ¼bner R, Ou Z, Dong X, He L, Wang H, Li J, Sun Y, Lu X, Zhuang X, Zheng Z*, Liu W*. Tungsten Oxide/Reduced Graphene Oxide Aerogel with Low-Content Platinum as High-Performance Electrocatalyst for Hydrogen Evolution Reaction. Small. 2021 Sep;17(37):e2102159
41: Lin Y#, Zhong X#, Xiong Z#, Zhang S, Liu M, Fan Y, Huang Y, Sun X, Zhou H, Xu X, Guo Y, Li Y, Yang D, Ye X, Zhuang X*, Liao X*. Intensity of Glycemic Exposure in Early Adulthood and Target Organ Damage in Middle Age: The CARDIA Study. Front Physiol. 2021 Jun 23;12:614532
42: Liu M#, Chen X#, Zhang S#, Lin Y, Xiong Z, Zhong X, Guo Y, Sun X, Zhou H, Xu X, Wang L, Liao X*, Zhuang X*. Long-Term Visit-to-Visit Mean Arterial Pressure Variability and the Risk of Heart Failure and All-Cause Mortality. Front Cardiovasc Med. 2021 Jun 4;8:665117
43: Lin Y#, Zhang S#, Wang S#, Zhong X, Li Y, Xiong Z, Sun X, Huang Y, Fan Y, Guo Y, Zhou H, Yang D, Liu M, Xu X, Zhuang X*, Liao X*. Behavioral Factors Mediating the Impact of Educational Attainment on Incident Heart Failureã€€- A Mediation Analysis. Circ J. 2021 Aug 25;85(9):1545-1552
44: Guo Y#, Zou J#, Xu X#, Zhou H, Sun X, Wu L, Zhang S, Zhong X, Xiong Z, Lin Y, Huang Y, Du Z, Liao X*, Zhuang X*. Short-chain fatty acids combined with intronic DNA methylation of HIF3A: Potential predictors for diabetic cardiomyopathy. Clin Nutr. 2021 Jun;40(6):3708-3717
45: Zang J#, Shi J#, Liang J#, Zhang X, Wei W, Yao C, Zhuang X*, Wu G*. Pulse Pressure, Cognition, and White Matter Lesions: A Mediation Analysis. Front Cardiovasc Med. 2021 May 4;8:654522
46: Wang K#, Zhang Z#, Mo ZS#, Yang XH, Lin BL, Peng L, Xu Y, Lei CY, Zhuang XD, Lu L, Yang RF, Chen T*, Gao ZL*. Gut microbiota as prognosis markers for patients with HBV-related acute-on-chronic liver failure. Gut Microbes. 2021 Jan- Dec;13(1):1-15
47: Liu M#, Zhang S#, Chen X#, Guo Y, Zhong X, Xiong Z, Lin Y, Zhou H, Huang Y, Zhang Z, Wang L, Zhuang X*, Liao X*. Appraisal of Guidelines for the Management of Blood Pressure in Patients with Diabetes Mellitus: The Consensuses, Controversies and Gaps. Diabetes Metab J. 2021 Sep;45(5):753-764
48: Liao LZ#, Wen XY#, Zhang SZ#, Li WD*, Zhuang XD*. Hypertension and Atrial Fibrillation: A Study on Epidemiology and Mendelian Randomization Causality. Front Cardiovasc Med. 2021 Mar 23;8:644405
49: Lin Y#, Zhong X#, Liu M#, Zhang S, Xiong Z, Huang Y, Fan Y, Xu X, Guo Y, Li Y, Sun X, Zhou H, Yang D, Ye X, Liao X*, Zhuang X*. Risk Stratification and Efficacy of Spironolactone in Patients with Heart Failure with Preserved Ejection Fraction: Secondary Analysis of the TOPCAT Randomized Clinical Trial. Cardiovasc Drugs Ther. 2022 Apr;36(2):323-331
50: Chen Z#, Liu M#, Zhang S#, Xiong Z, Zhong X, Yang D, Kong J, He X, Zhu Y, Hu X*, Zhuang X*. Urban index and lifestyle risk factors for cardiovascular diseases in China: A cross-sectional study. Sci Prog. 2021 Jan-Mar;104(1):368504211003762
51: Liao LZ#, Chen ZC#, Li WD#, Zhuang XD*, Liao XX*. Causal effect of education on type 2 diabetes: A network Mendelian randomization study. World J Diabetes. 2021 Mar 15;12(3):261-277
52: Liu M#, Zhang S#, Chen X#, Zhong X, Xiong Z, Yang D, Lin Y, Huang Y, Li Y, Wang L, Zhuang X*, Liao X*. Association of Mid- to Late-Life Blood Pressure Patterns With Risk of Subsequent Coronary Heart Disease and Death. Front Cardiovasc Med. 2021 Feb 15;8:632514
53: Zang J#, Liang J#, Zhuang X#, Zhang S, Liao X*, Wu G*. Intensive blood pressure treatment in coronary artery disease: implications from the Systolic Blood Pressure Intervention Trial (SPRINT). J Hum Hypertens. 2022 Jan;36(1):86-94
54: Zhuang X#, Sun X#, Zhou H#, Zhang S, Zhong X, Xu X, Guo Y, Xiong Z, Liu M, Lin Y, Zhang M*, Liao X*. Klotho attenuated Doxorubicin-induced cardiomyopathy by alleviating Dynamin-related protein 1 - mediated mitochondrial dysfunction. Mech Ageing Dev. 2021 Apr;195:111442
55: Xie P#, Zhuang X#, Liu M#, Zhang S, Liu J, Liu D*, Liao X*. An appraisal of clinical practice guidelines for the appropriate use of echocardiography for adult infective endocarditis-the timing and mode of assessment (TTE or TEE). BMC Infect Dis. 2021 Jan 21;21(1):92
56: Zhang S#, Zhuang X#, Lv Q#, Du Z, Zhou H, Zhong X, Sun X, Xiong Z, Hu X, Yang D, Zhang M*, Liao X*. Six-Year Change in QT Interval Duration and Risk of Incident Heart Failureã€€- A Secondary Analysis of the Atherosclerosis Risk in Communities Study. Circ J. 2021 Apr 23;85(5):640-646
57: Zhuang XD#, Zhang SZ#, Liao LZ#, Lin X, Zhou HM, Zhong XB, Sun XT, Du ZM, Zhang MF*, Liao XX*. Serum Albumin and Incident Heart Failure: Insights From Epidemiological and Mendelian Randomization Studies. Circ Genom Precis Med. 2020 Dec;13(6):e002989
58: Liao LZ#, Zhuang XD#, Zhang SZ#, Liao XX*, Li WD*. Education and heart failure: New insights from the atherosclerosis risk in communities study and mendelian randomization study. Int J Cardiol. 2021 Feb 1;324:115-121
59: Sun XT#, Zeng C#, Zhang SZ#, Zhou HM, Zhong XB, Xiong ZY, Yang DY, Guo Y, Zhuang XD*, Liao XX*. Long-term tracking of fasting blood glucose variability and peripheral artery disease in people without diabetes. BMJ Open Diabetes Res Care. 2020 Sep;8(1):e000896
60: Zhang ZZ#, Zhang SZ#, Zhou HM#, Fan YQ, Liu MH, Zhong XB, Yang DY, Guo Y, Zhuang XD*, Liao XX*. A systematic review of guidelines for dual antiplatelet therapy in coronary artery bypass graft. Eur J Clin Invest. 2021 Jan;51(1):e13405
61: Chen T#, Liu L#, Zhang L#, Lu T, Matos RL, Jiang C, Lin Y, Yuan T, Ma Z, He H, Zhuang X*, Li Q*. Optimization of the supercritical fluidized bed process for sirolimus coating and drug release. Int J Pharm. 2020 Nov 15;589:119809
62: Huang Y#, Zhang S#, Liu M#, Zhong X, Lin Y, Xiong Z, Fan Y, Zhou H, Sun X, Guo Y, Xu X, Li Y, Yang D, Zhuang X*, Liao X*. Impact of RAAS Blockers on Contrast- Induced Nephropathy in Patients With Renal Insufficiency: A Meta-Analysis. J Cardiovasc Pharmacol. 2020 Dec;76(6):692-697
63: Liu M#, Zhuang X#, Chen X#, Zhang S, Yang D, Zhong X, Xiong Z, Lin Y, Zhou H, Fan Y, Xie P, Huang Y, Wang L*, Liao X*. Antiplatelet strategy in primary and secondary prevention of cardiovascular disease in patients with typeÂ 2 diabetes mellitus: A perspective from the guideline appraisal. J Diabetes Investig. 2021 Jan;12(1):99-108
64: Hu X#, Zhuang XD#, Mei WY#, Liu G, Du ZM, Liao XX*, Li Y*. Exploring the causal pathway from body mass index to coronary heart disease: a network Mendelian randomization study. Ther Adv Chronic Dis. 2020 May 27;11:2040622320909040
65: Liang J#, Zhang H#, Sun X#, Liao L, Li X, Hu X, Du J, Zhuang X*, Liao X*. Association between calf girth and peripheral artery disease in the Atherosclerosis Risk in Communities Study. J Cardiol. 2020 Sep;76(3):273-279
66: Liao LZ#, Li WD#, Liu Y#, Li JP, Zhuang XD*, Liao XX*. Causal assessment of sleep on coronary heart disease. Sleep Med. 2020 Mar;67:232-236
67: Liao LZ#, Zhang SZ#, Li WD#, Liu Y, Li JP, Zhuang XD*, Liao XX*. Serum albumin and atrial fibrillation: insights from epidemiological and mendelian randomization studies. Eur J Epidemiol. 2020 Feb;35(2):113-122
68: Zhang L#, Sun X#, Liao L#, Zhang S, Zhou H, Zhong X, Zhuang X*, Liao X*. Effectiveness of blood pressure-lowering treatment by the levels of baseline Framingham risk score: A post hoc analysis of the Systolic Blood Pressure Intervention Trial (SPRINT). J Clin Hypertens (Greenwich). 2019 Dec;21(12):1813-1820
69: Liu C#, Cao Y#, He X#, Zhang C, Liu J, Zhang L, Wu D, Zhuang X, Xue R, Huang H, Jiang J, Dong B, Sun Y, Dong Y*, Zhao J*. Association of Cyr61-cysteine-rich protein 61 and short-term mortality in patients with acute heart failure and coronary heart disease. Biomark Med. 2019 Dec;13(18):1589-1597
70: Liao LZ#, Li WD#, Liu Y#, Li JP, Zhuang XD*, Liao XX*. Exploring the causal pathway from omega-6 levels to coronary heart disease: A network Mendelian randomization study. Nutr Metab Cardiovasc Dis. 2020 Feb 10;30(2):233-240
71: Zhang S#, Zhou H#, Zhuang X#, Yang D, Sun X, Zhong X, Lin X, Hu X, Huang Y, Liao X*, Du Z*. Critical appraisal of guidelines for coronary artery disease on dual antiplatelet therapy: More consensus than controversies. Clin Cardiol. 2019 Dec;42(12):1170-1180
72: Zhou H#, Zhang S#, Sun X#, Yang D, Zhuang X, Guo Y, Hu X, Du Z, Zhang M*, Liao X*. Lipid management for coronary heart disease patients: an appraisal of updated international guidelines applying Appraisal of Guidelines for Research and Evaluation II-clinical practice guideline appraisal for lipid management in coronary heart disease. J Thorac Dis. 2019 Aug;11(8):3534-3546
73: Xiong Z#, Li J#, Zhong X#, Zhang S, Sun X, Zhou H, Chen Y, Zhuang X*, Liao X*. Visit-to-Visit Fasting Glucose Variability in Young Adulthood and Hippocampal Integrity and Volume at Midlife. Diabetes Care. 2019 Dec;42(12):2334-2337
74: Zhang S#, Zhuang X#*, Liao X#*. Letter by Zhang et al Regarding Article, "Twenty Year Trends and Sex Differences in Young Adults Hospitalized With Acute Myocardial Infarction: The ARIC Community Surveillance Study". Circulation. 2019 Aug 20;140(8):e329-e330
75: Yang DY#, Nie ZQ#, Liao LZ#, Zhang SZ, Zhou HM, Sun XT, Zhong XB, Du ZM, Zhuang XD*, Liao XX*. Phenomapping of subgroups in hypertensive patients using unsupervised data-driven cluster analysis: An exploratory study of the SPRINT trial. Eur J Prev Cardiol. 2019 Nov;26(16):1693-1706
76: Zhang S#, Zhuang X#, Lin X#, Zhong X, Zhou H, Sun X, Xiong Z, Huang Y, Fan Y, Guo Y, Du Z*, Liao X*. Low-Carbohydrate Diets and Risk of Incident Atrial Fibrillation: AÂ Prospective Cohort Study. J Am Heart Assoc. 2019 May 7;8(9):e011955
77: Yang DY#, He X#, Liang HW#, Zhang SZ, Zhong XB, Luo CF, Du ZM, He JG, Zhuang XD*, Liao XX*. Comparative outcomes of heart failure among existent classes of anti-diabetic agents: a network meta-analysis of 171,253 participants from 91 randomized controlled trials. Cardiovasc Diabetol. 2019 Apr 8;18(1):47
78: He Y#, Zhu Z#, Chen Y#, Chen F, Wang Y, Ouyang C, Yang H, Huang M, Zhuang X, Mao R, Ben-Horin S, Wu X, Ouyang Q, Qian J, Lu N, Hu P*, Chen M*. Development and Validation of a Novel Diagnostic Nomogram to Differentiate Between Intestinal Tuberculosis and Crohn's Disease: A 6-year Prospective Multicenter Study. Am J Gastroenterol. 2019 Mar;114(3):490-499
79: Sun X#, Zhuang X#, Huo M#, Feng P, Zhang S, Zhong X, Zhou H, Guo Y, Hu X, Du Z, Zhang M*, Liao X*. Serum magnesium and the prevalence of peripheral artery disease: The Atherosclerosis Risk in Communities (ARIC) study. Atherosclerosis. 2019 Mar;282:196-201
80: Sun X#, Guo Y#, Nie Z#, Cheng J, Zhou H, Zhong X, Zhang S, Du Z, Zhuang X*, Liao X*. Influence of baseline systolic blood pressure on the relationship between intensive blood pressure control and cardiovascular outcomes in the Systolic Blood Pressure Intervention Trial (SPRINT). Clin Res Cardiol. 2019 Mar;108(3):273-281
81: Zhang J#, Xiao Y#, Yang D#, Zhuang X, Wang L, Gao X*, Huang Z*. Correction to: Development of a new risk nomogram of perioperative major adverse cardiac events for Chinese patients undergoing colorectal carcinoma surgery. Int J Colorectal Dis. 2018 Aug;33(8):1147
82: Zhuang X#, Guo Y#, Ni A#, Yang D, Liao L, Zhang S, Zhou H, Sun X, Wang L, Wang X*, Liao X*. Toward a panoramic perspective of the association between environmental factors and cardiovascular disease: An environment-wide association study from National Health and Nutrition Examination Survey 1999-2014. Environ Int. 2018 Sep;118:146-153
83: Zhuang XD#, He X#, Yang DY#, Guo Y, He JG, Xiao HP*, Liao XX*. Comparative cardiovascular outcomes in the era of novel anti-diabetic agents: a comprehensive network meta-analysis of 166,371 participants from 170 randomized controlled trials. Cardiovasc Diabetol. 2018 Jun 5;17(1):79
84: Zhang L#, Zhuang X#*, Liao X#*. A proposed Oxford classification-based clinicopathological nomogram for predicting short-term renal outcomes in IgA nephropathy after acute kidney injury. Eur J Intern Med. 2018 Jun;52:60-66
85: Liao L#, Zhuang X#, Li W#, Su Q, Zhao J*, Liu Y*. Polysaccharide from Fuzi protects against Oxâ€‘LDLâ€‘induced calcification of human vascular smooth muscle cells by increasing autophagic activity. Mol Med Rep. 2018 Apr;17(4):5109-5115
86: Zhuang X#, Ni A#, Liao L#, Guo Y, Dai W, Jiang Y, Zhou H, Hu X, Du Z, Wang X*, Liao X*. Environment-wide association study to identify novel factors associated with peripheral arterial disease: Evidence from the National Health and Nutrition Examination Survey (1999-2004). Atherosclerosis. 2018 Feb;269:172-177
87: Long M#, Huang Z#, Zhuang X#, Huang Z, Guo Y, Liao X*, Luo C*. Association of Inflammation and Endothelial Dysfunction with Coronary Microvascular Resistance in Patients with Cardiac Syndrome X. Arq Bras Cardiol. 2017 Nov;109(5):397-403
88: Guo Y#, Zhuang X#, Huang Z#, Zou J, Yang D, Hu X, Du Z, Wang L*, Liao X*. Klotho protects the heart from hyperglycemia-induced injury by inactivating ROS and NF- ÎºB-mediated inflammation both in vitro and in vivo. Biochim Biophys Acta Mol Basis Dis. 2018 Jan;1864(1):238-251
89: Guo Y#, Zhuang XD#, Xian WB#, Wu LL, Huang ZN, Hu X, Zhang XS, Chen L*, Liao XX*. Serum Klotho, vitamin D, and homocysteine in combination predict the outcomes of Chinese patients with multiple system atrophy. CNS Neurosci Ther. 2017 Aug;23(8):657-666
90: Zhang J#, Xiao Y#, Yang D#, Zhuang X, Wang L, Gao X*, Huang Z*. Development of a new risk nomogram of perioperative major adverse cardiac events for Chinese patients undergoing colorectal carcinoma surgery. Int J Colorectal Dis. 2017 Aug;32(8):1157-1164
91: Lu Y#, Hu XM#, Huang XL#, Zhuang XD, Guo P, Feng LF, Hu W, Chen L, Zou H*, Hao YT*. The relationship between job satisfaction, work stress, work-family conflict, and turnover intention among physicians in Guangdong, China: a cross- sectional study. BMJ Open. 2017 May 12;7(5):e014894
92: Hu X#, Zhuang XD#, Li Y#, Li FF, Guo Y, Du ZM*, Liao XX*. A Nomogram to Predict Contrast Induced Nephropathy in Patients Undergoing Percutaneous Coronary Intervention. Int Heart J. 2017 Apr 6;58(2):191-196
93: Huang Z#, Zhuang X#, Xie C#, Hu X, Dong X, Guo Y, Li S*, Liao X*. Exogenous Hydrogen Sulfide Attenuates High Glucose-Induced Cardiotoxicity by Inhibiting NLRP3 Inflammasome Activation by Suppressing TLR4/NF-ÎºB Pathway in H9c2 Cells. Cell Physiol Biochem. 2016;40(6):1578-1590
94: Huang Z#, Dong X#, Zhuang X#, Hu X, Wang L*, Liao X*. Exogenous hydrogen sulfide protects against high glucoseâ€‘induced inflammation and cytotoxicity in H9c2 cardiac cells. Mol Med Rep. 2016 Nov;14(5):4911-4917
95: Lu Y#, Hu XM#, Huang XL#, Zhuang XD, Guo P, Feng LF, Hu W, Chen L*, Hao YT*. Job satisfaction and associated factors among healthcare staff: a cross-sectional study in Guangdong Province, China. BMJ Open. 2016 Jul 19;6(7):e011388
96: Zhuang X#, Peng Y#, Bardeesi AS#, Bardisi ES, Liao X*, Luo C*. Vessel heterogeneity of TIMI frame count and its relation to P-wave dispersion in patients with coronary slow flow. J Thorac Dis. 2016 Mar;8(3):476-81
97: Zhuang XD#, Liao LZ#, Dong XB#, Hu X, Guo Y, Du ZM, Liao XX*, Wang LC*. Design, synthesis, and antihypertensive activity of curcumin-inspired compounds via ACE inhibition and vasodilation, along with a bioavailability study for possible benefit in cardiovascular diseases. Drug Des Devel Ther. 2016 Jan 5;10:129-39
98: Zhang H#, Zhuang XD#, Meng FH#, Chen L, Dong XB, Liu GH, Li JH, Dong Q, Xu JD*, Yang CT*. Calcitriol prevents peripheral RSC96 Schwann neural cells from high glucose & methylglyoxal-induced injury through restoration of CBS/H2S expression. Neurochem Int. 2016 Jan;92:49-57
99: He WM#, Luo YT#, Shui X#, Liao XX, Liu JL*, Zhuang XD*. Critical appraisal of international guidelines on chronic heart failure: Can China AGREE? Int J Cardiol. 2016 Jan 15;203:111-4. 
100: Luo D#, Zhuang X#, Luo C#, Long M, Deng C, Liao X*, Wang L*. Continuous angiotensin-(1-7) infusion improves myocardial calcium transient and calcium transient alternans in ischemia-induced cardiac dysfunction rats. Biochem Biophys Res Commun. 2015 Nov 27;467(4):645-50
101: Chen J#, Zhuang X#, Long M#, Su C*, Wang L*. Efficacy and Safety of Edoxaban in Nonvalvular Atrial Fibrillation: A Meta-analysis of Randomized Controlled Trials. J Stroke Cerebrovasc Dis. 2015 Dec;24(12):2710-9
102: Zhuang XD#, Liao LZ#, Guo Y#, Li Y, Liao XX, Hu X*, Du ZM*. Rationale and design of RETAIN study: Rosuvastatin Effect on Telomere-telomerase system in Acute coronary syndrome patients undergoing percutaneous coronary Intervention. Int J Cardiol. 2015 Apr 1;184:388-390
103: Zhou Y#, Guo Y#, Zhuang X#*, Du Z*. Docosahexanoic acid modifies low-density lipoprotein receptor abundance in HepG2 cells via suppression of the LXRÎ±-Idol pathway. Mol Med Rep. 2015 Mar;11(3):2329-33
104: Chen J#, Zhuang X#, Liao L#, Liao X*, Wang L*. Efficacy of isolated left ventricular and biventricular pacing is differentially associated with baseline QRS duration in chronic heart failure: a meta-analysis of randomized controlled trials. Heart Fail Rev. 2015 Jan;20(1):81-8
105: Zhuang XD#, Long M#, Li CL#, Hu CH, Du ZM*, Liao XX*. Efficacy and safety of low-dose clopidogrel after 12-month dual antiplatelet therapy for patients having drug-eluting stent implantation. J Thorac Dis. 2014 May;6(5):459-65
106: Zhuang XD#, Hu X#, Long M#, Dong XB, Liu DH*, Liao XX*. Exogenous hydrogen sulfide alleviates high glucose-induced cardiotoxicity via inhibition of leptin signaling in H9c2 cells. Mol Cell Biochem. 2014 Jun;391(1-2):147-55
107: Zhuang XD#, Long M#, Li F#, Hu X, Liao XX*, Du ZM*. PDE5 inhibitor sildenafil in the treatment of heart failure: a meta-analysis of randomized controlled trials. Int J Cardiol. 2014 Apr 1;172(3):581-7
108: Chen YL#, Zhuang XD#, Xu ZW#, Lu LH, Guo HL, Wu WK*, Liao XX*. Higenamine Combined with [6]-Gingerol Suppresses Doxorubicin-Triggered Oxidative Stress and Apoptosis in Cardiomyocytes via Upregulation of PI3K/Akt Pathway. Evid Based Complement Alternat Med. 2013;2013:970490
109: Peng L#, Zhuang X#, Liao L#, He X, Li J, Chen X, Lu G, Ma H*, Gao X*. Changes in cell autophagy and apoptosis during age-related left ventricular remodeling in mice and their potential mechanisms. Biochem Biophys Res Commun. 2013 Jan 11;430(2):822-6
